Edited byIan M. Anderson, BA, MA, MBBS, MD, MRCP(UK), FRCPsych, is a professor of psychiatry in the Neuroscience and Psychiatry Unit at the University of Manchester, UK. He also is an honorary consultant psychiatrist at the Manchester Mental Health and Social Care Trust, UK. Dr. Anderson founded the Specialist Service for Affective Disorders in Manchester and was its director until 2011. His research interests include the aetiology and treatment of mood disorders, the mechanism of action of antidepressants and evidence-based psychiatry. He chaired the guideline development group for the 2009 update of the NICE depression clinical guideline and is an author on several consensus treatment guidelines from the British Association for Psychopharmacology (BAP). He is a past general secretary of the BAP.R. Hamish McAllister-Williams, BSc, MBChB, PhD, MD, FRCPsych, is a reader in clinical psychopharmacology at the Institute of Neuroscience in Newcastle University, UK. He is also an honorary consultant psychiatrist in the Regional Affective Disorders Service at the Northumberland Tyne and Wear NHS Foundation Trust, UK. Dr. McAllister-Williams is the lead consultant in the tertiary level Regional Affective Disorders Service based in Newcastle for patients with treatment-refractory mood disorders. His research focuses on the pathophysiology and treatment of both bipolar and unipolar affective disorders, and he is an author of the British Association for Psychopharmacology (BAP) consensus guidelines for treating depression. He is a past general secretary of the BAP and was appointed its director of education in 2012.

"This is an excellent resource that is easy to read, succinct but complete, and is based solely on research findings. I have read many psychopharmacology books, but this is one of the best because of how well it compiles a vast amount of information in short chapters. While the chapters about specific medications and conditions are well written, the chapters on research and basic prescribing practices are exceptional and complement the other chapters."—Aaron Plattner, MD, Doody’s Book Reviews

• Neuropharmacology and Drug Action. Pharmacokinetics and Pharmacodynamics. Antipsychotics. Antidepressants and ECT. Mood Stabilisers and Other Treatments for Bipolar Disorder. Anxiolytic and Hypnotic Drugs. Drugs of Abuse. Drugs for Dementia and Cognitive Impairment. Drugs Used for Personality Disorders and Behavioural Disturbance. Drug Treatments for Child and Adolescent Disorders. Prescribing in Clinical Practice. Clinical Trial Methodology.

Edited byIan M. Anderson, BA, MA, MBBS, MD, MRCP(UK), FRCPsych, is a professor of psychiatry in the Neuroscience and Psychiatry Unit at the University of Manchester, UK. He also is an honorary consultant psychiatrist at the Manchester Mental Health and Social Care Trust, UK. Dr. Anderson founded the Specialist Service for Affective Disorders in Manchester and was its director until 2011. His research interests include the aetiology and treatment of mood disorders, the mechanism of action of antidepressants and evidence-based psychiatry. He chaired the guideline development group for the 2009 update of the NICE depression clinical guideline and is an author on several consensus treatment guidelines from the British Association for Psychopharmacology (BAP). He is a past general secretary of the BAP.R. Hamish McAllister-Williams, BSc, MBChB, PhD, MD, FRCPsych, is a reader in clinical psychopharmacology at the Institute of Neuroscience in Newcastle University, UK. He is also an honorary consultant psychiatrist in the Regional Affective Disorders Service at the Northumberland Tyne and Wear NHS Foundation Trust, UK. Dr. McAllister-Williams is the lead consultant in the tertiary level Regional Affective Disorders Service based in Newcastle for patients with treatment-refractory mood disorders. His research focuses on the pathophysiology and treatment of both bipolar and unipolar affective disorders, and he is an author of the British Association for Psychopharmacology (BAP) consensus guidelines for treating depression. He is a past general secretary of the BAP and was appointed its director of education in 2012.

"This is an excellent resource that is easy to read, succinct but complete, and is based solely on research findings. I have read many psychopharmacology books, but this is one of the best because of how well it compiles a vast amount of information in short chapters. While the chapters about specific medications and conditions are well written, the chapters on research and basic prescribing practices are exceptional and complement the other chapters."—Aaron Plattner, MD, Doody’s Book Reviews

• Neuropharmacology and Drug Action. Pharmacokinetics and Pharmacodynamics. Antipsychotics. Antidepressants and ECT. Mood Stabilisers and Other Treatments for Bipolar Disorder. Anxiolytic and Hypnotic Drugs. Drugs of Abuse. Drugs for Dementia and Cognitive Impairment. Drugs Used for Personality Disorders and Behavioural Disturbance. Drug Treatments for Child and Adolescent Disorders. Prescribing in Clinical Practice. Clinical Trial Methodology.

Edited byIan M. Anderson, BA, MA, MBBS, MD, MRCP(UK), FRCPsych, is a professor of psychiatry in the Neuroscience and Psychiatry Unit at the University of Manchester, UK. He also is an honorary consultant psychiatrist at the Manchester Mental Health and Social Care Trust, UK. Dr. Anderson founded the Specialist Service for Affective Disorders in Manchester and was its director until 2011. His research interests include the aetiology and treatment of mood disorders, the mechanism of action of antidepressants and evidence-based psychiatry. He chaired the guideline development group for the 2009 update of the NICE depression clinical guideline and is an author on several consensus treatment guidelines from the British Association for Psychopharmacology (BAP). He is a past general secretary of the BAP.R. Hamish McAllister-Williams, BSc, MBChB, PhD, MD, FRCPsych, is a reader in clinical psychopharmacology at the Institute of Neuroscience in Newcastle University, UK. He is also an honorary consultant psychiatrist in the Regional Affective Disorders Service at the Northumberland Tyne and Wear NHS Foundation Trust, UK. Dr. McAllister-Williams is the lead consultant in the tertiary level Regional Affective Disorders Service based in Newcastle for patients with treatment-refractory mood disorders. His research focuses on the pathophysiology and treatment of both bipolar and unipolar affective disorders, and he is an author of the British Association for Psychopharmacology (BAP) consensus guidelines for treating depression. He is a past general secretary of the BAP and was appointed its director of education in 2012.

"This is an excellent resource that is easy to read, succinct but complete, and is based solely on research findings. I have read many psychopharmacology books, but this is one of the best because of how well it compiles a vast amount of information in short chapters. While the chapters about specific medications and conditions are well written, the chapters on research and basic prescribing practices are exceptional and complement the other chapters."—Aaron Plattner, MD, Doody’s Book Reviews

• Neuropharmacology and Drug Action. Pharmacokinetics and Pharmacodynamics. Antipsychotics. Antidepressants and ECT. Mood Stabilisers and Other Treatments for Bipolar Disorder. Anxiolytic and Hypnotic Drugs. Drugs of Abuse. Drugs for Dementia and Cognitive Impairment. Drugs Used for Personality Disorders and Behavioural Disturbance. Drug Treatments for Child and Adolescent Disorders. Prescribing in Clinical Practice. Clinical Trial Methodology.